The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Diversity of Mechanism-Based Pharmacodynamic Models
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Comparison of four basic models of indirect pharmacodynamic responses
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061691 · Cited by 821
Self-citationPharmacokinetic/pharmacodynamic data analysis : concepts and applications
Gabrielsson, J., & Weiner, D. (2002) · Cited by 711
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605
Self-citationKinetics of pharmacologic response
Holford, N. H. G., & Sheiner, L. B. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90051-1 · Cited by 501
The Pharmacology of Vascular Smooth Muscle
(1996) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780192623874.001.0001 · Cited by 439
Physiologic indirect response models characterize diverse types of pharmacodynamic effects
Jusko, W. J., & Ko, H. C. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.155 · Cited by 360
Self-citation
Cited by
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
The Hill equation: a review of its capabilities in pharmacological modelling
Goutelle, S., Maurin, M., Rougier, F., Barbaut, X., Bourguignon, L., Ducher, M., & Maire, P. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00633.x · Cited by 867
In silico toxicology: computational methods for the prediction of chemical toxicity
Raies, A. B., & Bajic, V. B. (2016) · WIREs Computational Molecular Science · doi:10.1002/wcms.1240 · Cited by 744
A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 484
Zou, H. Y., Friboulet, L., Kodack, D. P., Engstrom, L. D., Li, Q., West, M., Tang, R. W., Wang, H., Tsaparikos, K., Wang, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.010 · Cited by 471
LALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
The Hill equation and the origin of quantitative pharmacology
Gesztelyi, R., Zsuga, J., Kemeny-Beke, A., Varga, B., Juhasz, B., & Tosaki, A. (2012) · Archive for History of Exact Sciences · doi:10.1007/s00407-012-0098-5 · Cited by 394
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
Fan, J., & de Lannoy, I. A. M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.007 · Cited by 309
Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Vauquelin, G., & Charlton, S. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00936.x · Cited by 298
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
DANHOF, M., DELANGE, E., DELLAPASQUA, O., PLOEGER, B., & VOSKUYL, R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.007 · Cited by 287
Zou, H. Y., Li, Q., Engstrom, L. D., West, M., Appleman, V., Wong, K. A., McTigue, M., Deng, Y.-L., Liu, W., Brooun, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420785112 · Cited by 267
Danhof, M., de Jongh, J., De Lange, E. C. M., Della Pasqua, O., Ploeger, B. A., & Voskuyl, R. A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105154 · Cited by 258
Tuntland, T., Ethell, B., Kosaka, T., Blasco, F., Zang, R. X., Jain, M., Gould, T., & Hoffmaster, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00174 · Cited by 239
Prantil-Baun, R., Novak, R., Das, D., Somayaji, M. R., Przekwas, A., & Ingber, D. E. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104748 · Cited by 176
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150
Wong, H., Choo, E. F., Alicke, B., Ding, X., La, H., McNamara, E., Theil, F.-P., Tibbitts, J., Friedman, L. S., Hop, C. E. C. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0738 · Cited by 133
Challenges and opportunities with modelling and simulation in drug discovery and drug development
Lavé, T., Parrott, N., Grimm, H. P., Fleury, A., & Reddy, M. (2007) · Xenobiotica · doi:10.1080/00498250701534885 · Cited by 115
Brinkmann, M., Preuss, T. G., & Hollert, H. (2016) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2015_5015 · Cited by 15
Gaohua, L., Maekawa, T., & Kimura, H. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.01.033 · Cited by 14
Metadata
- Authors
- Mager, D. E., Wyska, E., & Jusko, W. J.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 31
- Issue
- 5
- Pages
- 510-518
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2107065429
- Cited by
- 345
- References
- 45
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.